ArticleBlood advances2024

The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN.

Marc Usart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.